Doç. Dr. EZGİ DENİZ BATU AKAL

Yayın Ağı

Makaleler 153

1. Subclinical Enthesitis in Children with Chronic Nonbacterial Osteomyelitis

ŞENER S., YILDIZ A. E., BATU AKAL E. D., ATALAY E., BAŞARAN H. Ö., BİLGİNER Y., et al.

TURKISH ARCHIVES OF PEDIATRICS , sa.3, 2025 (ESCI, TRDizin)

2. Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

Vitale A., Caggiano V., Sbalchiero J., TUFAN A., BATU AKAL E. D., Ragab G., et al.

RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus)

3. Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: A scoping review

Sener S., BATU AKAL E. D.

SEMINARS IN ARTHRITIS AND RHEUMATISM , 2025 (SCI-Expanded, Scopus)

4. Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry

Ruscitti P., Di Cola I., Vitale A., Caggiano V., Palumbo P., Di Cesare E., et al.

JOURNAL OF RHEUMATOLOGY , sa.3, ss.226-233, 2025 (SCI-Expanded, Scopus)

5. Influence of gender on Behcet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behcet's Disease Registry

Sota J., Ragab G., AlMaglouth I., Lopalco G., TUFAN A., DİRESKENELİ R. H., et al.

JOINT BONE SPINE , sa.2, 2025 (SCI-Expanded, Scopus)

6. Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network

Vitale A., Leone F., Caggiano V., Hinojosa-Azaola A., Martin-Nares E., Guaracha-Basanez G. A., et al.

FRONTIERS IN PHARMACOLOGY , 2025 (SCI-Expanded, Scopus)

7. Treatment of systemic juvenile idiopathic arthritis: conventional treatment versus biologics

Şener S., Batu E. D., BAŞARAN ö., balık z., Aliyev E., BAYINDIR Y., et al.

Turkish Journal of Pediatrics , cilt.67, sa.1, ss.61-68, 2025 (SCI-Expanded, Scopus, TRDizin)

8. The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry

Ruscitti P., Vitale A., Di Cola I., Caggiano V., Palumbo P., Di Cesare E., et al.

RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus)

9. Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review

BATU AKAL E. D., ŞENER S., Rodrigues M., Vinit C., Hofer F., Laskari K., et al.

RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus)

10. Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry

Vitale A., Caggiano V., Leone F., Hinojosa-Azaola A., Martin-Nares E., Guaracha-Basanez G. A., et al.

FRONTIERS IN PHARMACOLOGY , 2025 (SCI-Expanded, Scopus)

11. Development and implementation of the international AIDA network spondylarthritis registry

Caggiano V., Vitale A., Hinojosa-Azaola A., Guaracha-Basanez G. A., Ruscitti P., Cipriani P., et al.

FRONTIERS IN MEDICINE , 2025 (SCI-Expanded, Scopus)

12. Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus

ŞENER S., BATU AKAL E. D., ÜNAL D., BAŞARAN H. Ö., SARIBAŞ Z., BİLGİNER Y., et al.

LUPUS , sa.1, ss.71-78, 2025 (SCI-Expanded, Scopus)

13. Differences and Similarities Between Children and Adults With Rhupus Syndrome

ŞENER S., ÜNAL D., BATU AKAL E. D., KART BAYRAM G. S., FIRLATAN YAZGAN B., KILIÇ L., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , sa.1, 2025 (SCI-Expanded, Scopus)

14. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

Sota J., Guerriero S., Lopalco G., TUFAN A., Ragab G., Almaglouth I., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , sa.1, ss.48-55, 2025 (SCI-Expanded, Scopus)

15. FAMILIAL MEDITERRANEAN FEVER FROM CHILDHOOD TO ADULTHOOD

BALIK Z., BATU AKAL E. D., BAŞARAN H. Ö., ÖZEN S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

16. Telemedicine in pediatric rheumatology: the video pediatric gait, arms, legs, and spine (v-pGALS) examination

BALIK Z., ŞENER S., BAYINDIR Y., CÜCEOĞLU M. K., ALİYEV E., BAŞARAN Ö., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.5, ss.963-969, 2024 (SCI-Expanded, Scopus, TRDizin)

17. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children

KAYA AKCA Ü., BATU AKAL E. D., Jelusic M., Calatroni M., Bakry R., Frkovic M., et al.

RHEUMATOLOGY , cilt.63, sa.SI2, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. REAL-LIFE DATA COMPARING THE LONG-TERM OUTCOME AND TREATMENT IN ADULT AND PEDIATRIC DADA2 PATIENTS: SINGLE CENTER EXPERIENCE OVER 10 YEARS

Ayan G., BAŞARAN H. Ö., BÖLEK E. Ç., FIRLATAN YAZGAN B., Bulat B., BATU AKAL E. D., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1113-1114, 2024 (SCI-Expanded, Scopus)

19. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature

ŞENER S., ÇAM V., ÖZEN S., BATU AKAL E. D.

Seminars in Arthritis and Rheumatism , cilt.66, 2024 (SCI-Expanded, Scopus)

20. Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever

ŞENER S., Atalay E., YILDIZ A. E., KASAP CÜCEOĞLU M., BAŞARAN H. Ö., BATU AKAL E. D., et al.

Modern Rheumatology , cilt.34, sa.3, ss.607-613, 2024 (SCI-Expanded, Scopus)

21. A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks

BATU AKAL E. D., Bayindir Y., Sener S., BALIK Z., Aliyev E., Kasap Cuceoglu M., et al.

RHEUMATOLOGY , cilt.64, sa.3, ss.1341-1346, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

Sener S., BATU AKAL E. D., Sahin S., Yildirim D. G., Ekinci M. K., KISAOĞLU H., et al.

Lupus , cilt.33, sa.3, ss.273-281, 2024 (SCI-Expanded, Scopus)

23. Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

ŞENER S., BATU AKAL E. D., Akca Ü. K., ATALAY E., Cüceoğlu M. K., BALIK Z., et al.

Turkish Archives of Pediatrics , cilt.59, sa.2, ss.150-156, 2024 (ESCI, Scopus, TRDizin)

24. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry

BATU AKAL E. D., ŞENER S., Aydin E. A., Aliyev E., Bagrul I., Türkmen Ş., et al.

Rheumatology (United Kingdom) , cilt.63, sa.3, ss.791-797, 2024 (SCI-Expanded, Scopus)

25. Biologic drugs in the treatment of juvenile dermatomyositis: a literature review

ŞENER S., ÇAM V., ÖZEN S., BATU AKAL E. D.

Clinical Rheumatology , cilt.43, sa.2, ss.591-602, 2024 (SCI-Expanded, Scopus)

26. Multisystem Inflammatory Syndrome in Children vs Kawasaki Disease: A Never-Ending Spectrum of Phenotypes

BATU AKAL E. D.

Canadian Journal of Cardiology , cilt.40, sa.1, ss.73-76, 2024 (SCI-Expanded, Scopus)

27. Preferential involvement of the pelvis and hips along with active sacroiliitis in chronic nonbacterial osteomyelitis: MRI of 97 patients from a single tertiary referral center

AYDINGÖZ Ü., YILDIZ A. E., AYAZ E., BATU AKAL E. D., ÖZEN S.

European Radiology , 2024 (SCI-Expanded, Scopus)

28. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?

BATU AKAL E. D., ŞENER S., BALIK Z., BAYINDIR Y., ÇAM V., KASAP CÜCEOĞLU M., et al.

Clinical Rheumatology , cilt.43, sa.1, ss.415-421, 2024 (SCI-Expanded, Scopus)

29. Chronic non-bacterial osteomyelitis and immune checkpoint molecules

KAYA AKCA Ü., SAĞ E., Aydın B., Tasdemir N. K., KASAP CÜCEOĞLU M., BAŞARAN H. Ö., et al.

Clinical Rheumatology , cilt.43, sa.1, ss.553-560, 2024 (SCI-Expanded, Scopus)

30. Drug-induced lupus erythematosus in childhood: Case-based review

KAYA AKCA Ü., ŞENER S., BATU AKAL E. D., BALIK Z., BAŞARAN H. Ö., BİLGİNER Y., et al.

Lupus , 2024 (SCI-Expanded, Scopus)

31. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

Vitale A., Caggiano V., TUFAN A., Ragab G., BATU AKAL E. D., Portincasa P., et al.

FRONTIERS IN IMMUNOLOGY , cilt.15, 2024 (SCI-Expanded, Scopus)

32. Other Immunomodulatory Treatment for Cytokine Storm Syndromes

BATU AKAL E. D., ÖZEN S.

CYTOKINE STORM SYNDROME, 2 EDITION , ss.601-609, 2024 (SCI-Expanded, Scopus)

33. Transition of patients with systemic lupus erythematosus from pediatric to adult- oriented rheumatology care

ŞENER S., Yardimci G. K., BATU AKAL E. D., KILIÇ L., Akca U. K., KASAP CÜCEOĞLU M., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , sa.6, ss.1198-1204, 2024 (SCI-Expanded, Scopus, TRDizin)

34. Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply

BATU AKAL E. D., ŞENER S., ÖZEN S.

ARTHRITIS & RHEUMATOLOGY , cilt.75, sa.12, ss.2266-2267, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study.

BATU AKAL E. D., DEMİRKAN F. G., Sag E., Lamot L., Faleye A., Marrani E., et al.

Seminars in arthritis and rheumatism , cilt.63, ss.152289, 2023 (SCI-Expanded, Scopus)

36. Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

ŞENER S., ÇAM V., BATU AKAL E. D., KASAP CÜCEOĞLU M., BALIK Z., Aliyev E., et al.

Rheumatology (Oxford, England) , cilt.62, sa.11, ss.3700-3705, 2023 (SCI-Expanded, Scopus)

37. Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients

Tümerdem B. Ş., AKBABA T. H., BATU AKAL E. D., AKKAYA ULUM Z. Y., MUTLU P., ÖZEN S., et al.

International Immunopharmacology , cilt.124, 2023 (SCI-Expanded, Scopus)

38. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data

BATU AKAL E. D., ŞENER S., ÇAM V., Aktay Ayaz N., ÖZEN S.

BioDrugs , cilt.37, sa.6, ss.813-828, 2023 (SCI-Expanded, Scopus)

39. Comparison of Biopsychosocial Characteristics of Children with Juvenile Idiopathic Arthritis According to Common Disease Subtypes

ŞENER S., KARACA N. B., KAŞLI K., ÖZÇADIRCI A., BATU AKAL E. D., BAŞARAN H. Ö., et al.

TURKISH ARCHIVES OF PEDIATRICS , cilt.58, ss.625-630, 2023 (ESCI, Scopus, TRDizin)

40. Cardiovascular manifestations of monogenic periodic fever syndromes

SÖNMEZ H. E., BAYINDIR Y., BATU AKAL E. D.

Clinical Rheumatology , cilt.42, sa.10, ss.2717-2732, 2023 (SCI-Expanded, Scopus)

41. Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study

Sestan M., Kifer N., Sozeri B., Demir F., Ulu K., Silva C. A., et al.

Seminars in Arthritis and Rheumatism , cilt.61, 2023 (SCI-Expanded, Scopus)

42. The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?

BATU AKAL E. D., ERDEN A.

International Journal of Rheumatic Diseases , cilt.26, sa.8, ss.1435-1439, 2023 (SCI-Expanded, Scopus)

43. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study

BATU AKAL E. D., Günalp A., Şahin S., Özdel S., Kızıldağ Z., PAÇ KISAARSLAN A., et al.

Rheumatology International , cilt.43, sa.8, ss.1485-1495, 2023 (SCI-Expanded, Scopus)

44. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

Kısaarslan A. P., Çiçek S. Ö., BATU AKAL E. D., Şahin S., Gürgöze M. K., Çetinkaya S. B., et al.

Joint Bone Spine , cilt.90, sa.4, 2023 (SCI-Expanded, Scopus)

45. Rice bodies in children with rheumatic disorders: A case series and systematic literature review

ŞENER S., Tanali G., ERGEN F. B., KASAP CÜCEOĞLU M., BALIK Z., BAYINDIR Y., et al.

MODERN RHEUMATOLOGY , cilt.33, ss.811-816, 2023 (SCI-Expanded, Scopus)

46. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †

BAŞARAN H. Ö., BATU AKAL E. D., KAYA AKCA Ü., ATALAY E., KASAP CÜCEOĞLU M., ŞENER S., et al.

Children , cilt.10, sa.6, 2023 (SCI-Expanded, Scopus)

47. Correspondence on 'Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus'

BATU AKAL E. D., KAYA AKCA Ü., BAŞARAN H. Ö., BİLGİNER Y., ÖZEN S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.82, sa.6, 2023 (SCI-Expanded, Scopus)

48. Predicting the Need for Additional Immunosuppressive Treatment in Pediatric Behçet’s Patients Pediatrik Behçet Hastalarında Ek İmmünsüpresif Tedavi Gereksiniminin Tahmin Edilmesi

ŞENER S., Dalarslan S., BATU AKAL E. D.

Guncel Pediatri , cilt.21, sa.1, ss.43-51, 2023 (ESCI, Scopus)

49. The Characteristics of Patients With COVID-19–Associated Pediatric Vasculitis: An International, Multicenter Study

BATU AKAL E. D., ŞENER S., Ozomay Baykal G., Arslanoglu Aydin E., Özdel S., Gagro A., et al.

Arthritis and Rheumatology , cilt.75, sa.4, ss.499-506, 2023 (SCI-Expanded, Scopus)

50. Evaluation of periodontal status and cytokine response in children with familial Mediterranean fever or systemic juvenile idiopathic arthritis

ACAR B., DEMİR S., ÖZŞİN ÖZLER C., TAN Ç., ÇİÇEK B., YAZ İ., et al.

CLINICAL ORAL INVESTIGATIONS , cilt.27, sa.3, ss.1159-1166, 2023 (SCI-Expanded, Scopus)

51. Report of 2 pediatric cases with atypical Cogan's syndrome and a systematic review

KASAP CÜCEOĞLU M., BAŞARAN H. Ö., BATU AKAL E. D., Kaya Akca U., Atalay E., ŞENER S., et al.

International Journal of Rheumatic Diseases , cilt.26, sa.3, ss.544-550, 2023 (SCI-Expanded, Scopus)

52. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides

ŞENER S., Aydin E. A., BATU AKAL E. D.

CLINICAL RHEUMATOLOGY , cilt.42, sa.3, ss.673-686, 2023 (SCI-Expanded, Scopus)

53. A new tool supporting the diagnosis of childhood-onset Behcet's disease: venous wall thickness

ATALAY E., OĞUZ B., ŞENER S., ÖZCAN H. N., SAĞ E., KAYA AKCA Ü., et al.

RHEUMATOLOGY , cilt.62, 2023 (SCI-Expanded, Scopus)

54. Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature

ŞENER S., BAŞARAN H. Ö., BATU AKAL E. D., Sag E., Oz S., TALİM B., et al.

Seminars in Arthritis and Rheumatism , cilt.58, 2023 (SCI-Expanded, Scopus)

55. A Child with Refractory and Relapsing Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Myopathy: Case-Based Review

ŞENER S., BATU AKAL E. D., SARI S., KASAP CÜCEOĞLU M., YILDIZ A. E., TALİM B., et al.

Journal of neuromuscular diseases , cilt.10, sa.2, ss.279-291, 2023 (SCI-Expanded, Scopus)

56. A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project

Gaggiano C., Del Bianco A., Sota J., Gentileschi S., Ruscitti P., Giacomelli R., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded, Scopus)

57. Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods

AKÇA Ü. K., Tanalı G., Batu E. D., ATALAY E., CU CEOG LU M. s. e. K., ŞENER S., et al.

Turkish archives of pediatrics (Online) , cilt.58, sa.1, ss.49-55, 2023 (TRDizin)

58. Reply on: COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis

BATU AKAL E. D., ŞENER S., ÖZEN S.

Seminars in Arthritis and Rheumatism , cilt.57, 2022 (SCI-Expanded, Scopus)

59. Diagnosing growing pains in children by using machine learning: a cross-sectional multicenter study

AKAL F., BATU AKAL E. D., Sonmez H. E., Karadag S. G., Demir F., Ayaz N. A., et al.

MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING , cilt.60, sa.12, ss.3601-3614, 2022 (SCI-Expanded, Scopus)

60. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents

ŞENER S., BAŞARAN H. Ö., KAYA AKCA Ü., ATALAY E., KASAP CÜCEOĞLU M., BALIK Z., et al.

RHEUMATOLOGY , cilt.61, ss.4885-4891, 2022 (SCI-Expanded, Scopus)

61. The challenges in diagnosing pediatric primary antiphospholipid syndrome

DEMİR S., KESKİN A., SAĞ E., KAYA AKCA Ü., ATALAY E., KASAP CÜCEOĞLU M., et al.

LUPUS , cilt.31, sa.10, ss.1269-1275, 2022 (SCI-Expanded, Scopus)

62. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis

BATU AKAL E. D., ŞENER S., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.55, 2022 (SCI-Expanded, Scopus)

63. Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study

BATU AKAL E. D., KAYA AKCA Ü., BAŞARAN H. Ö., BİLGİNER Y., ÖZEN S.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.7, ss.1207-1211, 2022 (SCI-Expanded, Scopus)

64. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study

KAYA AKCA Ü., BATU AKAL E. D., ŞENER S., BALIK Z., KASAP CÜCEOĞLU M., ATALAY E., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.6, ss.1785-1792, 2022 (SCI-Expanded, Scopus)

65. Factors Affecting Nonurgent Pediatric Emergency Department Visits and Parental Emergency Overestimation

PEHLİVANTÜRK KIZILKAN M., Ozsezen B., BATU AKAL E. D.

PEDIATRIC EMERGENCY CARE , cilt.38, sa.6, ss.264-268, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene

BATU AKAL E. D., BAŞARAN H. Ö., BİLGİNER Y., ÖZEN S.

CURRENT RHEUMATOLOGY REPORTS , cilt.24, sa.6, ss.206-212, 2022 (SCI-Expanded, Scopus)

67. Long-term renal survival of paediatric patients with lupus nephritis

Demir S., GÜLHAN B., ÖZEN S., Çelĕgen K., BATU AKAL E. D., Taş N., et al.

Nephrology Dialysis Transplantation , cilt.37, sa.6, ss.1069-1077, 2022 (SCI-Expanded, Scopus)

68. Macrophage activation syndrome in pediatric Sjogren's syndrome

BATU AKAL E. D., DEMİR S., BİLGİNER Y., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.53, 2022 (SCI-Expanded, Scopus)

69. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

Sozeri B., Ulu K., KAYA AKCA Ü., HAŞLAK F., PAÇ KISAARSLAN A., Otar-Yener G., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.3, ss.469-475, 2022 (SCI-Expanded, Scopus)

70. Comparison of IVIG resistance predictive models in Kawasaki disease

KAYA AKCA Ü., Aydin E. A., AYKAN H. H., SERİN O., SAĞ E., DEMİR S., et al.

PEDIATRIC RESEARCH , cilt.91, sa.3, ss.621-626, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Subcutaneous nodules as a clinical biomarker of Farber disease

Mitchell J., Harmatz P., Selim L., El Din I. G., Mungan N., Bulut F., et al.

MOLECULAR GENETICS AND METABOLISM , cilt.135, sa.2, 2022 (SCI-Expanded, Scopus)

72. Farber disease clinical impact: Patient reported outcomes as a measure of disease burden

Mitchell J., Harmatz P., Selim L., El Din I. G., Mungan N., Bulut F., et al.

MOLECULAR GENETICS AND METABOLISM , cilt.135, sa.2, 2022 (SCI-Expanded, Scopus)

73. The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort

Bustaffa M., Kone-Paut I., ÖZEN S., Amaryan G., Papadopoulou-Alataki E., Gallizzi R., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.52, 2022 (SCI-Expanded, Scopus)

74. Galectin-3: a new biomarker for differentiating periodic fever, adenitis, pharyngitis, aphthous stomatitis (PFAPA) syndrome from familial Mediterranean fever?

BATU AKAL E. D., Vezir E., Ogus E., Ozbas Demirel O., Akpinar G., DEMİR S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.71-80, 2022 (SCI-Expanded, Scopus)

75. Two siblings with Majeed syndrome and neutropenia

KASAP CÜCEOĞLU M., BATU AKAL E. D., YILDIZ A. E., Kaya Akca U., Atalay E., ŞENER S., et al.

Archives of Rheumatology , cilt.37, sa.4, ss.638-640, 2022 (SCI-Expanded, Scopus, TRDizin)

76. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study

KAYA AKCA Ü., BATU AKAL E. D., PAÇ KISAARSLAN A., Poyrazoglu H., Ayaz N. A., Sozeri B., et al.

LUPUS , cilt.30, sa.10, ss.1700-1708, 2021 (SCI-Expanded, Scopus)

77. Penile involvement of immunoglobulin a vasculitis/Henoch-Schonlein purpura

KAYA AKCA Ü., BATU AKAL E. D., SERİN O., Ipek O. F., Aydin O., TEKŞAM Ö., et al.

JOURNAL OF PEDIATRIC UROLOGY , cilt.17, sa.3, 2021 (SCI-Expanded, Scopus)

78. Oral health status in children with familial Mediterranean fever

Esmeray P., İLERİ KEÇELİ T., UZAMIŞ TEKÇİÇEK M., BATU AKAL E. D., Arici Z. S., KONŞUK ÜNLÜ H., et al.

TURKISH JOURNAL OF PEDIATRICS , cilt.63, sa.3, ss.443-449, 2021 (SCI-Expanded, Scopus, TRDizin)

79. Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients

SAĞ E., KESKİN A., ATALAY E., DEMİR S., KASAP CÜCEOĞLU M., KAYA AKCA Ü., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.1, ss.87-93, 2021 (SCI-Expanded, Scopus)

80. Implications of COVID-19 in pediatric rheumatology

BATU AKAL E. D., ÖZEN S.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.8, ss.1193-1213, 2020 (SCI-Expanded, Scopus)

81. Neutrophil-mediated Thrombosis and NETosis in Behcet's Disease: a Hypothesis

BATU AKAL E. D.

JOURNAL OF KOREAN MEDICAL SCIENCE , cilt.35, sa.29, 2020 (SCI-Expanded, Scopus)

82. Characteristics of pediatric Behcet's disease in Turkey and Israel: A cross-sectional cohort comparison

Aviel Y. B., BATU AKAL E. D., Sozeri B., Ayaz N. A., Baba L., Amarilyo G., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.50, sa.3, ss.515-520, 2020 (SCI-Expanded, Scopus)

83. Lipoma Arborescens Associated With Psoriatic Arthritis in an Adolescent Boy A Case Report and Review of the Literature

Batu E. D., Sonmez H., Kösemehmetoğlu K., Özer H., Aydingöz Ü.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.26, sa.2, 2020 (SCI-Expanded, Scopus)

84. Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis

ÖZEN S., DEMİR S., BATU AKAL E. D.

JOURNAL OF RHEUMATOLOGY , cilt.46, sa.10, ss.1422-1423, 2019 (SCI-Expanded, Scopus)

85. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period

Salimov A., Akyol U., ÇILDIR B., BATU AKAL E. D., Cozen S.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY , cilt.119, ss.185-192, 2019 (SCI-Expanded, Scopus)

86. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?

Sonmez H. E., Esmeray P., Batu E. D., Arici Z. S., DEMİR S., SAĞ E., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.39, sa.1, ss.83-87, 2019 (SCI-Expanded, Scopus)

87. Çocuk Romatoloji Polikliniğine Anti-Nükleer Antikor (ANA)Pozitifliği ile Yönlendirilen Hastaların Özellikleri

BATU AKAL E. D., SÖNMEZ H. E., BİLGİNER Y.

Türkiye Çocuk Hastalıkları Dergisi , cilt.13, sa.1, ss.13-18, 2019 (TRDizin)

88. Glucocorticoid treatment in juvenile idiopathic arthritis

Batu E. D.

RHEUMATOLOGY INTERNATIONAL , cilt.39, sa.1, ss.13-27, 2019 (SCI-Expanded, Scopus)

89. Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus

Batu E. D., Koşukcu C., Taşkıran E., Sahin S., Akman S., Sözeri B., et al.

JOURNAL OF RHEUMATOLOGY , cilt.45, sa.12, ss.1671-1679, 2018 (SCI-Expanded, Scopus)

90. Genetic testing for DADA2: How can we avoid missing patients?

SÖNMEZ H. E., BATU AKAL E. D., Taskiran E. Z., ALİKAŞİFOĞLU M., BİLGİNER Y., ÖZEN S.

EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.26, sa.11, ss.1563-1564, 2018 (SCI-Expanded, Scopus)

91. A patient heterozygous for R92Q mutation with periodic fever and aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome-like phenotype

BATU AKAL E. D., SÖNMEZ H. E., BİLGİNER Y., ÖZEN S.

TURKISH JOURNAL OF PEDIATRICS , cilt.60, sa.6, ss.726-728, 2018 (SCI-Expanded, Scopus, TRDizin)

92. Comparing immunoglobulin A vasculitis (Henoch-Schonlein purpura) in children and adults: a single-centre study from Turkey

Batu E. D., Sari A., Erden A., Sonmez H. E., Armagan B., Kalyoncu U., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.47, sa.6, ss.481-486, 2018 (SCI-Expanded, Scopus)

93. Monogenic systemic lupus erythematosus: insights in pathophysiology

Batu E. D.

RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.10, ss.1763-1775, 2018 (SCI-Expanded, Scopus)

94. Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease

TOPALOĞLU R., BATU AKAL E. D., Yildiz C., Korkmaz E., ÖZEN S., BEŞBAŞ N., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, sa.10, ss.1857-1862, 2018 (SCI-Expanded, Scopus)

95. Vasculitis Pathogenesis: Can We Talk About Precision Medicine?

ÖZEN S., Batu E. D.

FRONTIERS IN IMMUNOLOGY , cilt.9, 2018 (SCI-Expanded, Scopus)

96. A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q

ÜNAL E., Batu E. D., Sonmez H. E., Arici Z. S., Arin G., KARACA N. B., et al.

RHEUMATOLOGY INTERNATIONAL , sa.8, ss.1557-1564, 2018 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

97. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance

ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.

BIOMARKERS IN MEDICINE , cilt.12, sa.6, ss.565-572, 2018 (SCI-Expanded, Scopus)

98. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Aeschlimann F. A., BATU AKAL E. D., Canna S. W., Go E., Gül A., Hoffmann P., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.5, ss.728-735, 2018 (SCI-Expanded, Scopus)

99. The Increased Frequency of Familial Mediterranean Fever in Patients Diagnosed with Immunoglobulin a Vasculitis (Henoch-Schonlein Purpura)

Sonmez H. E., Batu E. D., Bilginer Y.

GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS , cilt.16, sa.1, ss.35-46, 2018 (ESCI, Scopus) Sürdürülebilir Kalkınma

100. Hypomorphic RAG1 defect in a child presented with pulmonary hemorrhage and digital necrosis

Taşkıran E., Sönmez H., Ayvaz D. N., Koşukcu C., Batu E. D., Esenboğa S., et al.

CLINICAL IMMUNOLOGY , cilt.187, ss.92-94, 2018 (SCI-Expanded, Scopus)

101. Immünoglobülin A Vasküliti (Henoch-Schönlein Purpura) Tanısı Olan Çocuk Hastalarda Artmış Ailevi Akdeniz Ateşi Sıklığı

SÖNMEZ H. E., BATU AKAL E. D., BİLGİNER Y.

Güncel Pediatri , cilt.16, sa.1, ss.35-46, 2018 (Scopus, TRDizin)

102. Çocuklarda Raynaud Fenomeni ve Birincil ve İkincil Raynaud Hastalarının Karşılaştırılması

BATU AKAL E. D., SÖNMEZ H. E., BİLGİNER Y.

Türkiye Çocuk Hastalıkları Dergisi , cilt.12, sa.1, ss.39-43, 2018 (TRDizin)

103. Increased psoriasis frequency in patients with familial Mediterranean fever

ERDEN A., BATU AKAL E. D., ŞEYHOĞLU E., SARI A., SÖNMEZ H. E., ARMAĞAN B., et al.

UPSALA JOURNAL OF MEDICAL SCIENCES , cilt.123, sa.1, ss.57-61, 2018 (SCI-Expanded, Scopus)

104. Acceptability and Practicality of the Turkish Translation of Pediatric Gait Arm Legs and Spine in Turkish Children

Batu E. D., Coskun O. K., Sonmez H. E., Karali D., Aydin E. A., BİLGİNER Y., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.23, sa.8, ss.421-424, 2017 (SCI-Expanded, Scopus)

105. Interferon Signature in Childhood Rheumatic Diseases

SÖNMEZ H. E., KARAASLAN İ. Ç., BATU AKAL E. D., Anlar B., Sozeri B., de Jesus A. A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

106. A20 Haploinsufficiency: Clinical Phenotypes and Disease Course of Patients with This Newly Recognized Autoinflammatory Disease

Aeschlimann F. A., BATU AKAL E. D., Go E., Gül A., Hoffmann P. M., Leavis H. L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

107. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?

ERDEN A., BATU AKAL E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., DEMİR S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

108. Blood Group "a" Was Increased in FMF Patients and Blood Group "0" May be Associated with Colchicine Resistance

ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

109. Childhood systemic vasculitis

SAĞ E., Batu E. D., ÖZEN S.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , cilt.31, sa.4, ss.558-575, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. Comparing polyarteritis nodosa in children and adults: a single center study

ERDEN A., BATU AKAL E. D., SÖNMEZ H. E., SARI A., ARMAĞAN B., ARICI Z. S., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded, Scopus)

111. Gastrointestinal system manifestations in juvenile systemic lupus erythematosus

Sonmez H. E., Karhan A. N., Batu E. D., BİLGİNER Y., Gumus E., DEMİR H., et al.

CLINICAL RHEUMATOLOGY , cilt.36, sa.7, ss.1521-1526, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management.

Özen S., BATU E. D., DEMIR S.

Frontiers in immunology , cilt.8, ss.253, 2017 (SCI-Expanded, Scopus)

113. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature

Batu E. D., Sonmez H. E., HAZIROLAN T., ÖZALTIN F., BİLGİNER Y., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.46, sa.4, ss.529-535, 2017 (SCI-Expanded, Scopus)

114. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants

Sonmez H. E., Batu E. D., BİLGİNER Y., ÖZEN S.

CLINICAL RHEUMATOLOGY , cilt.36, sa.2, ss.421-425, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

115. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases

Batu E. D., Erden A., Seyhoglu E., KILIÇ L., BÜYÜKAŞIK Y., KARADAĞ Ö., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.46, sa.1, ss.44-48, 2017 (SCI-Expanded, Scopus)

116. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis

BATU AKAL E. D., SÖNMEZ H. E., GÜLHAN B., ARICI Z. S., TOPALOĞLU R., BİLGİNER Y.

TURKISH JOURNAL OF PEDIATRICS , cilt.59, sa.1, ss.6-12, 2017 (SCI-Expanded, Scopus, TRDizin)

117. Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy

Sonmez H. E., Batu E. D., Demir S., Bilginer Y., Ozen S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.6, 2017 (SCI-Expanded, Scopus)

118. The performance of different classification criteria in paediatric Behcet's disease

Batu E. D., Sonmez H. E., Sozeri B., Aviel Y. B., Bilginer Y., Ozen S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.6, 2017 (SCI-Expanded, Scopus)

119. Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas.

BATU E. D., Kara E., TSOUKAS P., HAUSMANN J., BILGINER Y., KENNA M., et al.

Arthritis care & research , cilt.68, ss.1859-1865, 2016 (SCI-Expanded, Scopus)

120. Whole Exome Sequencing in Early Onset Systemic Lupus Erythematosus

BATU AKAL E. D., KOŞUKCU C., Taskiran E. Z., AKMAN S., Ozturk K., SÖZERİ B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

121. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus

AYTAC Ş. S., Batu E. D., ÜNAL Ş., BİLGİNER Y., ÇETİN M., TUNCER M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.36, sa.10, ss.1421-1429, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

122. The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)

ERDEN A., BATU AKAL E. D., Taskiran E. Z., SÖNMEZ H. E., SARI A., ARMAĞAN B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

123. BehcEt's Disease in Children: Eastern Mediterranean Experience

SÖNMEZ H. E., BATU AKAL E. D., SÖZERİ B., Aviel Y. B., BİLGİNER Y., ÖZEN S.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

124. Biologic therapies in systemic juvenile idiopathic arthritis

BATU AKAL E. D.

EXPERT OPINION ON ORPHAN DRUGS , cilt.4, sa.6, ss.621-629, 2016 (SCI-Expanded, Scopus)

125. Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature

BİLGİNER Y., DÜZOVA A., TOPALOĞLU R., Batu E. D., Boduroglu K., Gucer S., et al.

LUPUS , cilt.25, sa.7, ss.760-765, 2016 (SCI-Expanded, Scopus)

126. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

ZHOU Q., WANG H., SCHWARTZ D. M., STOFFELS M., PARK Y. H., ZHANG Y., et al.

NATURE GENETICS , cilt.48, sa.1, ss.67-75, 2016 (SCI-Expanded, Scopus)

127. Familial Mediterranean fever: current perspectives

Sonmez H. E., Batu E. D., ÖZEN S.

JOURNAL OF INFLAMMATION RESEARCH , cilt.9, ss.13-20, 2016 (ESCI, Scopus)

128. Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO)

Batu E. D., ERGEN F. B., GÜLHAN B., TOPALOĞLU R., AYDINGÖZ Ü., ÖZEN S.

JOINT BONE SPINE , cilt.82, sa.6, ss.471-473, 2015 (SCI-Expanded, Scopus)

129. Development of a Juvenile Systemic Sclerosis Response Index (JSSRI)

Foeldvari I., Zoltan G., Baildam E., BATU AKAL E. D., Blakley M., Cakan M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

130. Vasculitis: do we know more to classify better?

Batu E. D., ÖZEN S.

PEDIATRIC NEPHROLOGY , cilt.30, sa.9, ss.1425-1432, 2015 (SCI-Expanded, Scopus)

131. ANTI- INTERLEUKIN 1 TREATMENT IN SECONDARY RENAL AMYLOIDOSIS ASSOCIATED WITH AUTOINFLAMMATORY DISEASES

TOPALOĞLU R., Batu E. D., ORHAN D., ÖZEN S., Besbas N.

PEDIATRIC NEPHROLOGY , cilt.30, sa.9, ss.1660, 2015 (SCI-Expanded, Scopus)

132. A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations

Batu E. D., KARADAĞ Ö., TASKIRAN E. Z., KALYONCU U., AKSENTIJEVICH I., ALİKAŞİFOĞLU M., et al.

JOURNAL OF RHEUMATOLOGY , cilt.42, sa.8, ss.1532-1534, 2015 (SCI-Expanded, Scopus)

133. Coexistence of systemic lupus erythematosus and familial Mediterranean fever

BATU E. D., ÖZEN S.

LUPUS , cilt.24, sa.9, ss.1006, 2015 (SCI-Expanded, Scopus)

134. The myths we believed in familial Mediterranean fever: what have we learned in the past years?

ÖZEN S., Batu E. D.

SEMINARS IN IMMUNOPATHOLOGY , cilt.37, sa.4, ss.363-369, 2015 (SCI-Expanded, Scopus)

135. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA

Erden A., Balu E. D., Arici Z. S., Bilgin E., Bilgen S. A., Karadagl O., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1113-1114, 2015 (SCI-Expanded, Scopus)

136. THE IMPACT OF CYCLOPHOSPHAMIDE EXPOSURE ON MENSTRUAL CYCLE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Arici Z. S., Batu E. D., Bilginer Y., Ozen S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1108, 2015 (SCI-Expanded, Scopus)

137. ASSESSMENT OF THE HSCORE FOR REACTIVE HEMOPHAGOCYTIC SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES

Batu E. D., Erden A., Seyhoglu E., Kilic L., Karadag O., Bilgen S. A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.398, 2015 (SCI-Expanded, Scopus)

138. DEVELOPMENT OF A JUVENILE SYSTEMIC SCLEROSIS RESPONSE INDEX (JSSRI)

Foeldvari I., Gyorgyi Z., Baildam E., Batu E. D., Blakley M., Cakan M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1227-1228, 2015 (SCI-Expanded, Scopus)

139. A CASE SERIES OF ADENOSINE DEAMINASE 2 DEFICIENT PATIENTS EMPHASIZING GENOTYPE-PHENOTYPE CORRELATIONS

Batu E. D., Karadag O., Taskiran E. Z., Kalyoncu U., Aksentijevich I., Ozen S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.518, 2015 (SCI-Expanded, Scopus)

140. THREE BEHCET'S DISEASE PATIENTS WITH PULMONARY ARTERY ANEURYSM

Arici Z. S., Kara-Eroglu F., Batu E. D., Besbas N., Hazirolan T., Dzova A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.395, 2015 (SCI-Expanded, Scopus)

141. Immunoglobulin G4-related orbital disease: a report of two paediatric cases

BATU E. D., ARICI Z. S., ORHAN D., KIRATLI H., ÖZEN S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.3, ss.409-410, 2015 (SCI-Expanded, Scopus)

142. THE FACTORS AFFECTING NEONATAL PRESENTATIONS TO THE PEDIATRIC EMERGENCY DEPARTMENT

BATU AKAL E. D., Yeni S., TEKŞAM Ö.

JOURNAL OF EMERGENCY MEDICINE , cilt.48, sa.5, ss.542-547, 2015 (SCI-Expanded, Scopus)

143. Vasculitis in children

Eleftheriou D., Batu E. D., ÖZEN S., Brogan P. A.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.30, 2015 (SCI-Expanded, Scopus)

144. Vertigo in childhood: A retrospective series of 100 children

BATU AKAL E. D., Anlar B., TOPÇU M., Turanli G., AYSÜN S.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , cilt.19, sa.2, ss.226-232, 2015 (SCI-Expanded, Scopus)

145. Reviewing the Recommendations for Lupus in Children

Arici Z. S., Batu E. D., ÖZEN S.

CURRENT RHEUMATOLOGY REPORTS , cilt.17, sa.3, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

146. Current therapeutic options for managing familial Mediterranean fever

Batu E. D., Arici Z. S., BİLGİNER Y., ÖZEN S.

EXPERT OPINION ON ORPHAN DRUGS , cilt.3, sa.9, ss.1063-1073, 2015 (SCI-Expanded, Scopus)

147. Systems-level analysis of genome wide association study results for a pilot juvenile idiopathic arthritis family study

Aydin-Son Y., Batu E. D., DEMIRKAYA E., BİLGİNER Y., Kasapcopur O., Unsal E., et al.

TURKISH JOURNAL OF PEDIATRICS , cilt.57, sa.4, ss.324-333, 2015 (SCI-Expanded, Scopus, TRDizin)

148. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes

Erdemli O., ÖZEN S., KESKİN D., Usanmaz A., Batu E. D., ATİLLA B., et al.

JOURNAL OF BIOMATERIALS APPLICATIONS , cilt.29, sa.4, ss.524-542, 2014 (SCI-Expanded, Scopus)

149. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study

SAĞ E., TARTAGLİONE A., BATU E. D., RAVELLİ A., KHALİL S. M. A., MARKS S. D., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.3, ss.440-444, 2014 (SCI-Expanded, Scopus)

150. Pediatric Onset of Behcet Syndrome

BATU AKAL E. D., Cimaz R., ÖZEN S.

BEHCET'S SYNDROME: FROM PATHOGENESIS TO TREATMENT , ss.165-176, 2014 (SCI-Expanded)

151. The performance of the new SLICC criteria for the classification of SLE in children

SAĞ E., Ravelli A., BATU AKAL E. D., Tartaglione A., Khalil S. M. A., Marks S., et al.

PEDIATRIC NEPHROLOGY , cilt.28, sa.8, ss.1548, 2013 (SCI-Expanded, Scopus)

152. Pediatric vasculitis.

BATU E. D., Ozen S.

Current rheumatology reports , cilt.14, ss.121-9, 2012 (SCI-Expanded, Scopus)

153. Anaphylactic Reaction Owing to Ondansetron Administration in a Child With Neuroblastoma and Safe Use of Granisetron: A Case Report

Demir H. A., BATU AKAL E. D., YALÇIN B., CİVELEK E., SAÇKESEN C., Buyukpamkcu M.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.32, sa.8, 2010 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 28

1. S12. The Relationship Between Self-Determination, Self-Efficacy, and Career Adaptability in Individuals With Juvenile Idiopathic Arthritis

BAYSAL YİĞİT A., TEMİZKAN E., BURAN S., Tüfekçi O., BAYINDIR Y., ARAN O. T., et al.

9th National 1st International Rheumatological Rehabilitation Congress, İzmir, Türkiye, 7 - 09 Ekim 2024, (Özet Bildiri)

2. KOLŞİSİNE DİRENÇLİ PEDİATRİK AAA HASTALARINDA ANTİ-IL1 TEDAVİSİ - HELIOS VERİ TABANI VERİLERİ

KASAP M., SAĞ E., AKAL F., ATALAY E., KAYA AKCA Ü., DEMİR S., et al.

5. Çocuk Romatoloji Kongresi, Türkiye, 12 - 13 Aralık 2020, (Özet Bildiri)

3. HYPERSENSITIVITY REACTIONS WITH DMARDS

KASAP CÜCEOĞLU M., SAĞ E., DEMİR S., KAYA AKCA Ü., ATALAY E., UYSAL SOYER Ö., et al.

Pediatric Rheumatology European Society (PReS) e-Congress-2020, BİLİNMEYEN ÜLKELER (DİĞER), 23 Eylül 2020, (Özet Bildiri)

4. COVID-19 IN PEDIATRIC RHEUMATOLOGY PATIENTS TREATED WITH BIOLOGIC DRUGS: A CROSS-SECTIONAL, PATIENT SURVEY STUDY

KASAP CÜCEOĞLU M., BATU AKAL E. D., DEMİR S., SAĞ E., KAYA AKCA Ü., ATALAY E., et al.

Pediatric Rheumatology European Society (PReS) e-Congress-2020, Online kongre, BİLİNMEYEN ÜLKELER (DİĞER), 23 - 25 Eylül 2020, (Özet Bildiri)

5. ANTI-IL1 TREATMENT IN COLCHICINE RESISTANT PAEDIATRIC FMF PATIENTS-REAL LIFE DATA FROM THE HELIOS REGISTRY

SAĞ E., AKAL F., ATALAY E., KAYA AKCA Ü., DEMİR S., Demirel D., et al.

EULAR 2020 e-congress, BİLİNMEYEN ÜLKELER (DİĞER), 3 - 05 Haziran 2020, cilt.79, ss.179-180, (Özet Bildiri)

6. Farber disease (acid ceramidase deficiency) natural history study: Prospective and retrospective clinical data

Mitchell J., Harmatz P., Grant C., Ferreira C. R., Lampe C., Selim L., et al.

16th Annual Research Meeting of the WORLDSymposium(TM), Florida, Amerika Birleşik Devletleri, 10 - 14 Şubat 2020, cilt.129, (Özet Bildiri)

7. AB0574 A MONOGENIC DISEASE WITH WIDE RANGE OF SYMPTOMS: DEFICIENCY OF ADENOSINE DEAMINASE 2

BATU AKAL E. D., TAŞKIRAN Z. E., TEZCAN F. İ., ÖZKARA H. A., ÇAĞDAŞ AYVAZ D. N., ÖZEN S., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1748, (Tam Metin Bildiri)

8. THE CHARACTERISTICS OF PEDIATRIC BEHCET'S DISEASE IN TURKEY VERSUS ISRAEL

Butbul Y., BATU AKAL E. D., SÖNMEZ H. E., Sozeri B., AKTAY AYAZ N., Baba L., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.424, (Özet Bildiri)

9. THE HELIOS (HACETTEPE UNIVERSITY ELECTRONIC RESEARCH FORMS) REGISTRY: USE OF BIOLOGIC DRUGS IN AUTOINFLAMMATORY DISEASES

DEMİR S., Batu E. D., AKAL F., SAĞ E., Akca U. K., Arslanoglu E., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1946-1947, (Özet Bildiri)

10. Possible Regulatory Effects Of miRNAs In The Pathogenesis Of Systemic Auto Inflammatory Diseases From The Perspective Of Familial Mediterranean Fever

AKKAYA ULUM Z. Y., TAVUKÇUOĞLU Z., BATU E. D., AKBABA T. H., SÖNMEZ H. E., PEYNİRCİOĞLU B., et al.

Autoinflammation 2019, 10.Uluslararası FMF ve SAID Kongresi, Cenova, İtalya, 31 Mart - 03 Nisan 2019, (Tam Metin Bildiri)

11. Farber disease (acid ceramidase deficiency): Data from an ongoing natural history study

Solyom A., Ferreira C., Mitchell J., Guelbert N., Mungan N., Bulut F., et al.

15th Annual Research Meeting of the WORLDSymposium(TM), Florida, Amerika Birleşik Devletleri, 4 - 07 Şubat 2019, cilt.126, (Özet Bildiri)

12. JIA’LI ÇOCUKLARIN BİYOPSİKOSOSYAL DURUMLARININ İNCELENMESİ

ÜNAL E., BATU AKAL E. D., SÖNMEZ H. E., ARICI Z. S., KISACIK P., ARIN BAL G., et al.

4. ULUSAL ROMATOLOJİK REHABİLİTASYON KONGRESİ, Türkiye, 29 - 30 Kasım 2018, (Özet Bildiri)

13. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCE

Sonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri)

14. JUVENİL İDİYOPATİK ARTRİTLİ ÇOCUKLARIN HASTALIK TİPLERİNE GÖRE ŞİKAYET TANIMLAMALARI

ÜNAL E., BİLGİNER Y., ARIN G., TÜRKMEN N. B., BATU E. D., ARICI Z. S., et al.

3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)

15. Oral Health in Children with Familial Mediterranean Fever

İLERİ KEÇELİ T., Esmeray P., BATU E. D., Arıcı Z. S., ÜNLÜ H., BİLGİNER Y., et al.

CED-IADR/NOF Oral Health Research Congress, Vienna, Avusturya, 21 - 23 Eylül 2017, (Özet Bildiri)

16. Distribution of vasculitides in Eastern mediteranean: Results of a prospective cohort

KARADAĞ Ö., ERDEN A., BATU E. D., BİLGİN E., UYAROGLU o., ŞEYHOĞLU E., et al.

EUROPEAN LEAGUE AGAİNST RHEUMATOLOGY ANNUAL MEETİNG 2017, 14 - 17 Haziran 2017, (Tam Metin Bildiri)

17. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)

BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.

5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)

18. DISTRIBUTION OF VASCULITIDES IN EASTERN MEDITERRANEAN: RESULTS OF A PROSPECTIVE COHORT

Karadag O., Erden A., Batu E. D., Bilgin E., Uyaroglu A. O., Seyhoglu E., et al.

Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.616, (Özet Bildiri)

19. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Erden A., Batu E. D., Bilgin E., Sonmez H. E., Seyhoglu E., Demir S., et al.

Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.414, (Özet Bildiri)

20. DIFFERENCES IN PERCEPTION OF THE DISEASE CONSTRAINTS BETWEEN THE CHILD AND PARENTS IN JIA

ÜNAL E., KISACIK P., Arin G., KARACA N. B., Batu E. D., Arici Z. S., et al.

Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1515, (Özet Bildiri)

21. ARE THE DEMOGRAPHIC AND CLINICAL FEATURES OF POLYARTERITIS NODOSA SIMILAR BETWEEN THE UK AND TURKEY?

Karadag O., Erden A., Batu E. D., Gopaluni S., Sari A., Armagan B., et al.

Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.329, (Özet Bildiri)

22. TWO-YEAR RESULTS OF A PROSPECTIVE VASCULITIS COHORT FROM EASTERN MEDITERRANEAN: DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES

KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., ARMAĞAN B., SARI A., ERDEN A., BATU AKAL E. D., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, (Özet Bildiri)

23. Pulmonary involvement in children with rheumatic diseases

EMİRALİOĞLU N., BATU E. D., SÖNMEZ H. E., TUĞCU G. D., ARICI Z. S., YALÇIN E. E., et al.

European Respiratory Society International Congress 2016, Londrina, Brezilya, 3 - 07 Eylül 2016, cilt.48, ss.4879

24. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN

Karadag O., Erden A., Bilgin E., Batu E. D., Armagan B., Sari A., et al.

Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri)

25. INVESTIGATION OF INTERACTION BETWEEN HAND DEXTERITY AND PARENTAL ATTITUDE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS

BERBEROĞLU U., ÜNAL E., Dizmek P., Arin G., BİLGİNER Y., Batu E. D., et al.

Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1265, (Özet Bildiri)

26. Farber disease: Implications of anti-inflammatory treatment

Mitchell J., SOLYOM A., Makay B., Arslan N., Batu E. D., ÖZEN S., et al.

12th Annual WORLD Symposium, California, Amerika Birleşik Devletleri, 29 Şubat - 04 Mart 2016, cilt.117, (Özet Bildiri)

27. Farber disease is characterized by typical features but a broad phenotypic spectrum: Selected information from a cohort of 37 patients

SOLYOM A., Mitchell J., EHLERT K., TANPAIBOON P., Magnusson B., Grigelioniene G., et al.

12th Annual WORLD Symposium, California, Amerika Birleşik Devletleri, 29 Şubat - 04 Mart 2016, cilt.117, (Özet Bildiri)

28. Cardiomyopathy in childhood: Results from a single tertiary care center

Batu E. D., Pehlivanturk M., Haliloglu G., Utine E., Tekerek N. U., Eroglu F. K., et al.

19th International Congress of the World-Muscle-Society, Berlin, Almanya, 7 - 11 Ekim 2014, cilt.24, ss.801, (Özet Bildiri)

Kitaplar 4

Metrikler

Yayın

185

Yayın (WoS)

167

Yayın (Scopus)

148

Atıf (WoS)

1341

H-İndeks (WoS)

Atıf (Scopus)

1919

H-İndeks (Scopus)

Atıf (Scholar)

138

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler